PULMOZYME 2500 U/2 clinical trials

Evaluation of the efficacy of intra venous dornase alfa (Pulmozyme®) on arterial recanalization in post-thrombectomy angiography in patients managed for ischemic stroke with thrombolysis and eligible for thrombectomy: a single-center phase II trial.

This study looks at whether a drug called Pulmozyme, given through a vein, can help clear blood clots in the brain after a stroke. It's for patients who have had a stroke and are having an operation to remove the clot, to see if Pulmozyme helps blood flow return to normal more quickly.